Briva 25 Tablet

About Briva 25 Tablet

Made by The ACME Laboratories Ltd., Briva 25 is a tablet whose active ingredient is Brivaracetam. Briva 25 is used to treat partial-onset seizures, a type of epilepsy where seizures begin in one part of the brain.

There are 10 brands of Brivaracetam listed in Bangladesh.

What is Briva 25 Tablet?

Briva 25 comes as a tablet with 25 mg of Brivaracetam, from The ACME Laboratories Ltd. Only a qualified doctor can decide whether it suits a particular person, and the dose and course are set by the doctor. It is taken together with other seizure medicines rather than on its own. The dose and duration are decided by the doctor based on the person's condition, weight and response to treatment.

Uses of Briva 25

Briva 25 is used to treat partial-onset seizures, a type of epilepsy where seizures begin in one part of the brain. It is intended for patients aged four years and older when taken by mouth. It is given as an add-on to other anti-epileptic medicines. Do not change or stop any seizure medicine without medical advice.

How to use Briva 25

It is an tablet, so measure the amount with a proper measuring device as instructed by the pharmacist. Briva 25 is taken by mouth. Swallow the tablet with water. Do not take extra tablets to make up for a missed one. Do not change the dose or stop early without asking your doctor. Complete the course exactly as prescribed.

Side effects of Briva 25

Tell the doctor if side effects bother you or do not go away. Seek immediate medical care for serious reactions such as mood changes, suicidal thoughts, breathing problems, or swelling of the face and throat. The most common side effects reported with Brivaracetam are sleepiness or sedation, dizziness, tiredness, and nausea or vomiting. Contact your doctor if you notice anything unusual after taking it. Tell your doctor about any side effect that bothers you.

Safety and precautions

Never stop the medicine suddenly without medical advice. People with an allergy to Brivaracetam or any ingredient in the tablet should not take it. Before starting Briva 25, tell your doctor about all your health conditions and medicines. Tell your doctor before starting if you are pregnant, planning a pregnancy or breastfeeding, because information on its use in these situations is limited.

Frequently asked questions

What is Briva 25 used for?

Briva 25 is used to treat partial-onset seizures, a type of epilepsy where seizures begin in one part of the brain. It is intended for patients aged four years and older when taken by mouth.

How do I use Briva 25 correctly?

It is an tablet, so measure the amount with a proper measuring device as instructed by the pharmacist. Briva 25 is taken by mouth.

Can Briva 25 cause side effects?

Tell the doctor if side effects bother you or do not go away. Seek immediate medical care for serious reactions such as mood changes, suicidal thoughts, breathing problems, or swelling of the face and throat.

Is Briva 25 safe for everyone?

Never stop the medicine suddenly without medical advice. People with an allergy to Brivaracetam or any ingredient in the tablet should not take it.

Indications

Brivaracetam is indicated for the treatment of partial-onset seizures in patients 4 years of age and older. As the safety of Brivaracetam injection in pediatric patients has not been established, Brivaracetam injection is indicated for the treatment of partial-onset seizures only in adult patients (16 years of age and older).

Pharmacology

The precise mechanism by which Brivaracetam exerts its anticonvulsant activity is not known. Brivaracetam displays a high and selective affinity for synaptic vesicle protein 2A (SV2A) in the brain, which may contribute to the anticonvulsant effect.

Brivaracetam binds SV2A with high affinity. SV2A is known to play a role in epileptogenesis through modulation of synaptic GABA release. It is thought that brivaracetam exerts its anti-epileptogenic effects through its binding to SV2A. Brivaracetam is also known to inhibit Na+ channels which may also contribute to its anti-epileptogenic action

Dosage & Administration

Adults (16 Years and older): The recommended starting dosage for monotherapy or adjunctive therapy is 50 mg twice daily (100 mg per day).

Based on individual patient tolerability and therapeutic response, the dosage may be adjusted down to 25 mg twice daily (50 mg per day) or up to 100 mg twice daily (200 mg per day).

Pediatric Patients (4 Years to less than 16 Years): The recommended dosage is based on body weight and is administered orally twice daily

Injection: for intravenous and adult use only when oral administration is temporarily not feasible; dosing is the same as oral regimen.

Interaction

Rifampin: Because of decreased concentrations, increasing Brivaracetam dosage in patients on concomitant rifampin is recommended.

Carbamazepine: Because of increased exposure to carbamazepine metabolite, if tolerability issues arise, consider reducing carbamazepine dosage in patients on concomitant Brivaracetam.

Phenytoin: Because phenytoin concentrations can increase, phenytoin levels should be monitored in patients on concomitant Brivaracetam.

Levetiracetam: Brivaracetam had no added therapeutic benefit when co-administered with levetiracetam.

Contraindications

Hypersensitivity to brivaracetam or any of the inactive ingredients in Brivaracetam

Side Effects

Most common adverse reactions (at least 5% for Brivaracetam and at least 2% more frequently than placebo) are somnolence/sedation, dizziness, fatigue, and nausea or vomiting.

Pregnancy & Lactation

There is a pregnancy exposure registry that monitors pregnancy outcomes in women exposed to antiepileptic drugs (AEDs), such as Brivaracetam, during pregnancy. No data are available regarding the presence of brivaracetam in human milk, the effects on the breastfed infant, or the effects of the drug on milk production. Studies in lactating rats have shown excretion of brivaracetam or metabolites in milk

Precautions & Warnings

Suicidal Behavior and Ideation: Monitor patients for suicidal behavior and ideation.

Neurological Adverse Reactions: Monitor for somnolence and fatigue, and advise patients not to drive or operate machinery until they have gained sufficient experience on Brivaracetam.

Psychiatric Adverse Reactions: Behavioral reactions including psychotic symptoms, irritability, depression, aggressive behavior, and anxiety; monitor patients for symptoms.

Hypersensitivity: Bronchospasm and Angioedema: Advise patients to seek immediate medical care. Discontinue and do not restart Brivaracetam if hypersensitivity occurs. 

Withdrawal of Antiepileptic Drugs: Brivaracetam should be gradually withdrawn.

Storage Conditions

Store at 25°C; excursions permitted between 15°C to 30°C

Alternative brands of Brivaracetam

Other brands with the same generic name, cheapest first.

Bivara Oral Solution

10 mg/ml

Brivaracetam

Advanced Chemical Industries PLC

Price not listed

Medicine information is for reference only and is not medical advice. Always follow your doctor's prescription and check with a pharmacist.